BioMimetic (BMTI) Down as FDA Doesn't Approve Augment Bone Graft PMA in Current Form

Go back to BioMimetic (BMTI) Down as FDA Doesn't Approve Augment Bone Graft PMA in Current Form
BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) Delayed: 9.49 --0 (-0%)
Previous Close $9.49    52 Week High $9.56 
Open $9.49    52 Week Low $2.01 
Day High $9.49    P/E N/A 
Day Low $9.49    EPS $-0.97 
Volume 1,100